Regarding the risk of allergic disease, patients with STAT3-HIES, despite elevated IgE levels, experience lower rates of allergy and anaphylaxis compared to individuals with similar IgE levels and atopic dermatitis, although these rates are still higher than in the general population [100,101]. This evidence concerns the gene STAT3 and atopic eczema.